Skip to main content

Aducanumab Treatment for Alzheimer’s is Getting a Second Chance

After 16 long years without any truly viable treatment options for Alzheimer’s, there is some optimism on the horizon in a stunning reversal on the formerly-rejected antibody therapy, aducanumab. The newest research reveals that large quantities of the medication do, in fact, decrease cognitive decline at the beginning stages of Alzheimer’s.

According to Rebecca Edelmayer, director of scientific engagement at the Alzheimer’s Association, “It could be a game-changer for the field. It could be one of the first disease-modifying therapies approved for Alzheimer’s disease.”

Biogen, the maker of aducanumab, reports significant benefits for dementia patients in a number of areas: activities of daily living, memory, language, and orientation. Biogen introduced its intentions to pursue regulatory approval in the U.S., with a long range aim of launching the medication internationally.

With an expected request for approval by the FDA as quickly as early 2020, the drug is slated to possibly become the first treatment method to actually reduce the clinical decline of Alzheimer’s. Additionally, it should open doors to many other treatment options that impact amyloid beta plaques, connecting other trials that target the immune system, inflammation, blood vessels, and synaptic cell health. Searching for the most beneficial management of the disease is a challenging endeavor, and it is likely that a variety of these approaches are likely to be necessary, according to Edelmayer.

The next challenge? Persuading the FDA to approve the treatment after earlier failed trials. If approved, aducanumab will first be provided to those who had signed up for earlier trials, and hopefully, soon offered to others dealing with all the challenges of Alzheimer’s as well.

For the approximate six million senior Americans battling Alzheimer’s (a number expected to more than double during the next three decades), plus the family who take care of them, these latest findings could be life-changing, as there are presently only minimally effective symptom-management medications available. As we await a treatment, the team at Heaven at Home Senior Care is ready to assist dementia patients with highly skilled, trained, and qualified caregivers who make the most of creative therapeutic approaches that focus on each person’s distinct strengths and ensure each individual is living to the fullest possible potential.

Families have options for in-home care in Dallas and surrounding areas that can help with Alzheimer’s care. To learn more about highly effective Alzheimer’s care that will help boost quality of life within the comfort of home, contact the dementia care experts at Heaven at Home Senior Care at 866-381-0500 and request an in-home assessment or additional information.

The post Aducanumab Treatment for Alzheimer’s is Getting a Second Chance appeared first on Heaven at Home Care.



from Heaven at Home Care https://ift.tt/2EAGGnP
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

The Connection Between Aging, Exercise, and Healthy Lungs

Enjoying a long and healthy retirement requires taking good care of yourself. While many people focus on living a heart-smart lifestyle, taking proactive steps to maintain healthy lungs is essential, too. As we age, the lungs become weaker and less flexible. This can contribute to a variety of diseases and chronic health conditions. According to the National Heart, Lung, and Blood Institute , lung-related illnesses are the 3rd leading cause of death in this country. That includes lung cancer, chronic obstructive pulmonary disease, and asthma—adding up to nearly 235,000 deaths a year. Here are a few tips you can use to keep your lungs healthy: Stop smoking. Talk with your primary care physician about smoking cessation programs. Avoid secondhand smoke. Research shows it can be just as deadly as being a smoker. Stay away from harsh chemicals. It’s important to avoid breathing in damaging fumes (e.g., home cleaners and weed killers). Prevent infections. Many infections can lead to ...
Post a Comment
Read more

How You Can Join the Fight Against Alzheimer’s

World Alzheimer’s Month in September is an opportunity to raise awareness about this complex disease and to challenge the stigmas surrounding dementia. Launched in 2012, the awareness month spotlights the fact that 2 out of every 3 people globally believe there is little understanding of dementia in their countries. More than 5 million Americans are living with Alzheimer’s or another dementia and it is the 6 th leading cause of death in the US, according to the Alzheimer’s Association’s annual report. With the senior population growing quickly, Alzheimer’s and dementia cases will continue to increase as well, unless researchers can find a cure. This upcoming Monday, Sept. 21, is World Alzheimer’s Day, a call to action for all of us to educate ourselves on how to take preventative steps, identify symptoms and support loved ones who have been diagnosed. Read more below to learn how to join the fight to end Alzheimer’s disease. Know the Warning Signs Detecting Alzheimer’s disea...
Post a Comment
Read more

Film Screening at Samvedna Senior Care

On 30th September, 2019, Samvedna Senior Care Foundation hosted the 2nd film festival of generations in association with Heidelberg University, Germany. The film Sputnik Moment – 30 years and beyond was screened at our senior citizen centre in Gurgaon for our members and staff. The film highlighted how senior citizens in Germany and the US were taking up second careers to fill their time, engage meaningfully and also get support through additional income. Post the screening Dr. Martin Gieselmann, Executive Secretary, SAI, Heidelberg University and Dr. Constanze, Coordinator DAAD Project, Heidelberg University along with our team engaged with the audience in an interesting discussion on the Indian scenario. Members shared that in India it is not easy for senior citizens to pick up jobs after retirement, however it was interesting to see that many in the audience did have jobs post retirement. They also spoke about stereotypes and social attitudes towards ageing and shared their per...
Post a Comment
Read more